79.87
Inari Medical Inc stock is traded at $79.87, with a volume of 751.79K.
It is down -0.03% in the last 24 hours and up +22.88% over the past month.
Inari Medical Inc is a medical device company focused on developing products to treat patients suffering from Chronic Venous Disease. Its product portfolio includes; ClotTriever, for the removal of the clot from peripheral blood vessels and treats patients suffering from deep vein thrombosis. The FlowTriever System product is used for the treatment of pulmonary embolism, InThrill system to treat small vessel thrombosis, LimFlow system and others. Geographically, the company generates majority of its revenue from United States and rest from International markets.
See More
Previous Close:
$79.89
Open:
$79.87
24h Volume:
751.79K
Relative Volume:
0.37
Market Cap:
$4.68B
Revenue:
$574.50M
Net Income/Loss:
$-78.58M
P/E Ratio:
-59.16
EPS:
-1.35
Net Cash Flow:
$1.58M
1W Performance:
+0.23%
1M Performance:
+22.88%
6M Performance:
+68.32%
1Y Performance:
+39.78%
Inari Medical Inc Stock (NARI) Company Profile
Name
Inari Medical Inc
Sector
Industry
Phone
949-923-4747
Address
6001 OAK CANYON, SUITE 100, IRVINE, CA
Compare NARI with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
NARI
Inari Medical Inc
|
79.87 | 4.68B | 574.50M | -78.58M | 1.58M | -1.35 |
![]()
ABT
Abbott Laboratories
|
128.22 | 222.39B | 41.95B | 13.40B | 6.49B | 7.65 |
![]()
BSX
Boston Scientific Corp
|
105.02 | 154.78B | 15.91B | 1.79B | 1.89B | 1.21 |
![]()
SYK
Stryker Corp
|
396.07 | 150.99B | 22.60B | 2.99B | 3.49B | 7.76 |
![]()
MDT
Medtronic Plc
|
90.82 | 116.46B | 33.00B | 4.29B | 5.50B | 3.27 |
![]()
EW
Edwards Lifesciences Corp
|
70.99 | 41.87B | 6.60B | 4.16B | 490.10M | 6.93 |
Inari Medical Inc Stock (NARI) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Dec-17-24 | Initiated | Oppenheimer | Outperform |
Sep-18-24 | Initiated | Stifel | Hold |
Sep-03-24 | Initiated | Leerink Partners | Market Perform |
Aug-09-24 | Initiated | Deutsche Bank | Buy |
Jul-25-24 | Initiated | William Blair | Outperform |
Jul-18-24 | Downgrade | Needham | Buy → Hold |
Feb-29-24 | Downgrade | Piper Sandler | Overweight → Neutral |
Jan-23-24 | Initiated | Needham | Buy |
Jul-19-23 | Initiated | Robert W. Baird | Outperform |
Oct-12-22 | Initiated | Jefferies | Buy |
Sep-29-22 | Initiated | Berenberg | Buy |
Sep-13-22 | Initiated | Truist | Hold |
Jun-21-22 | Initiated | Piper Sandler | Overweight |
Mar-23-22 | Resumed | BofA Securities | Buy |
Dec-15-20 | Upgrade | Wells Fargo | Equal Weight → Overweight |
Nov-18-20 | Initiated | BTIG Research | Buy |
Oct-29-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
Sep-28-20 | Initiated | SVB Leerink | Outperform |
Jun-19-20 | Initiated | Canaccord Genuity | Buy |
Jun-16-20 | Initiated | BofA/Merrill | Neutral |
Jun-16-20 | Initiated | Morgan Stanley | Equal-Weight |
Jun-16-20 | Initiated | Wells Fargo | Equal Weight |
View All
Inari Medical Inc Stock (NARI) Latest News
Bronstein, Gewirtz & Grossman, LLC Is Investigating Inari Medical, Inc. (NARI) And Encourages Investors to Connect - Markets Insider
Bronstein, Gewirtz & Grossman, LLC Encourages Inari Medical, Inc. (NARI) Stockholders to Inquire about Securities Investigation - Markets Insider
Reasons to Retain Inari Medical Stock in Your Portfolio for Now - Nasdaq
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Inari Medical, Inc. (NARI) And Encourages Stockholders to Reach Out - Markets Insider
Stryker, Inari Medical, HSR waiting period expired Feb. 3 - MLex
Jennison Associates LLC Raises Stock Holdings in Inari Medical, Inc. (NASDAQ:NARI) - MarketBeat
Inari Medical, Inc. (NASDAQ:NARI) Receives Average Recommendation of "Hold" from Analysts - MarketBeat
NARI SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Inari Medical, Inc. Stockholders Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Inari Medical, Inc. (NASDAQ:NARI) Short Interest Down 38.8% in January - MarketBeat
Inari Medical, Inc. (NARI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - Markets Insider
Inari Medical (NASDAQ:NARI) Reaches New 1-Year HighHere's What Happened - MarketBeat
Stryker to sell spinal implants business - MedTech Dive
(NARI) On The My Stocks Page - Stock Traders Daily
Inari Medical stock soars to 52-week high of $79.7 - MSN
Inari Medical (NASDAQ:NARI) Sets New 52-Week HighWhat's Next? - MarketBeat
Is Inari Medical, Inc. (NARI) the Hottest Smid-Cap Stock So Far In 2025? - MSN
Inari Medical stock soars to 52-week high of $79.7 By Investing.com - Investing.com South Africa
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates NARI, QTRX, CTV on Behalf of Shareholders - GlobeNewswire Inc.
$HAREHOLDER ALERT: The M&A Class Action Firm Encourages Stockholders of NARI, DFS, LBRDA, CCRN to Act - The Eastern Progress Online
AMI Asset Management Corp Makes New $1.65 Million Investment in Inari Medical, Inc. (NASDAQ:NARI) - MarketBeat
Why Is Inari Medical, Inc. (NARI) Among the Hottest Mid-Cap Stocks So Far in 2025? - MSN
Uncovering the Best Performing Mid-Cap Stocks! Don't Miss Out! - Jomfruland.net
Stryker begins tender offer for Inari Medical shares at $80 each By Investing.com - Investing.com South Africa
Stryker begins tender offer for Inari Medical shares at $80 each - MSN
Stryker commences tender offer for all outstanding shares of common stock of Inari Medical - MSN
Stryker commences $80 per share cash offer for Inari Medical - TipRanks
Stryker commences tender offer for all outstanding shares of common stock of Inari Medical, Inc. - The Manila Times
Here’s Why Inari Medical, Inc. (NARI) Is Skyrocketing - MSN
Are You Looking for a Top Momentum Pick? Why Inari Medical, Inc. (NARI) is a Great Choice - MSN
Here’s Why Jim Cramer Backs Stryker (SYK)’s $4.9 Billion Inari Medical Acquisition - Insider Monkey
Stryker agrees to acquire Inari Medical for $4.9bn - MSN
Stryker to Acquire Inari Medical for $4.9B - Orange County Business Journal
Here’s Why Inari Medical Inc. (NARI) Led This Week’s Rally - MSN
J&J explores bid for Intra-Cellular Therapies, Bloomberg News reports - Reuters
Plug Power, Capri And Frontline Are Among Top Mid Cap Gainers Last Week (Jan 6-10): Are The Others In Your Portfolio? - Benzinga
Here’s Why Inari Medical Inc. (NASDAQ:NARI) Is Skyrocketing - MSN
Inari Medical soars on Stryker acquisition - MSN
Stryker Stock Falls Despite the Agreement to Acquire Inari Medical - MSN
Stryker to acquire Inari Medical in $4.9 billion deal, expand into peripheral vascular segment - DOTmed HealthCare Business News
Inari Medical Inc Stock (NARI) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):